ORAI3 and breast cancer: However, SOCE in less aggressive, estrogen receptor positive luminal subtype of breast cancer cells occurs mainly through ORAI3 [24], and upon loss of estrogen receptor alpha, metastatic cells appear to switch to SOCE through the ORAI1 channel, [23, 24].